The worldwide drug-delivery arena is growing each year as the increasing aging population is in need of improved methods of administration for products and therapies. Drug-delivery industry growth is being led by the United States as well as emerging markets.
This PharmaLive Special Report concentrates on the market leaders and technologies expected to head this sector in years to come. This compilation’s prescription-product pipeline details the following information for each medicine:
- Chemical or substance composition
- Intended indication
- Class of drug
- Clinical status
- Region of development
- Product developer/intended marketer
In addition, the pipeline status details preclinical development, Phase I through Phase III, and awaiting approval. Regions of development include the United States, Europe, and Japan. A directory of prescription-drug developers and marketers is included.
Also provided in this report is a listing of drug-delivery medical devices, sorted by device class, as well as a directory of medical-device companies associated with this industry sector.